About CxPM

Dementia can be devastating.
The CxPM team is devoted to revolutionizing geriatric medicine, one biomarker at a time.

Cx Precision Medicine is dedicated to Changing Expectations.

Cx Precision Medicine’s technology is licensed from the University of North Texas Health Science Center (UNTHSC) laboratory of Sid O’Bryant, Ph. D., one of the world’s leading experts in blood-based biomarkers for Alzheimer’s disease and other neurodegenerative diseases. Dr. O’Bryant is the founder of the company and Professor of Pharmacology and Neuroscience at UNTHSC.

The company’s technology takes the guesswork out of initial diagnoses of neurodegenerative diseases and represents a paradigm shift away from one-size-fits-all treatments to a precision medicine approach, recognizing differences among patients based on their genetics, environment and lifestyle.

CxPM intellectual properties include 13 issued patents in four patent families.

The CxPM Team

Danguole Altman, MBA
CEO

Carol Berry, MBA
Business Development

Darlene Boudreaux, CPA
CFO

Heather Giles, PhD
COO

Steve Hunsucker, PhD
Lab Operations

Daniel Tessier, PhD
Project Manager

Advisors

Sid O’Bryant, PhD
Scientific Founder & Advisory Board Chair

Valerie Palmieri
Advisory Board Member

Paula Steiner
Advisory Board Member

Jeff Keyser, PhD, RPh, JD
Advisory Board Member

Board of Directors

Danguole Altman
CEO

Bob Ferguson
Chair & Treasurer

Ed Lasater, JD
Secretary

Cameron Cushman
Member

Jeff Keyser, PhD
Member